点心债
Search documents
点心债如何助推人民币国际化
Sou Hu Cai Jing· 2026-01-29 18:16
2007年6月,中国人民银行与国家发展改革委联合发布《境内金融机构赴香港特别行政区发行人民币债券管理暂行办法》,允许境内政策性 银行和商业银行在香港发行人民币债券。首批发行机构主要为政策性银行和国有商业银行,债券以2至3年期为主,票面利率约3%。2009 年,财政部发行第一只离岸人民币国债,为市场确立了初步的无风险利率基准。 快速扩张期(2010—2014年) 次贷危机后,主要发达经济体实施量化宽松政策,而中国利率水平显著高于海外,人民币处于单边升值通道。投资者持有人民币资产可同 时获得票息收益和汇率升值的双重回报。2010年7月,香港金管局放宽对境外企业发行人民币债券的限制。同年8月,麦当劳成为首家发行 点心债的非中资企业,随后卡特彼勒、联合利华、大众汽车纷纷跟进。发行规模从2010年的358亿元增至2011年的1310亿元,至2014年达到 约4300亿元。 编者按 点心债是 在离岸市场发行和交易的人民币债券,因早期规模较小而得名。经过近二十年发展,点心债已从边缘试验品种成长为离岸人民币 资产体系的核心支柱。2024年点心债发行规模达到11734亿元,首次突破万亿关口,同比增长27%。在中美利差倒挂与境内 ...
资金动向 | 北水连续16日加仓阿里巴巴,抛售美团近17亿港元
Ge Long Hui A P P· 2025-09-12 12:29
Group 1 - The net buying of stocks by southbound funds includes Alibaba-W at 4.38 billion, Tencent Holdings at 0.929 billion, Pop Mart at 0.642 billion, Hua Hong Semiconductor at 0.401 billion, Kangfang Biotech at 0.225 billion, and Yaojie Ankang-B at 0.18 billion, while net selling includes Meituan-W at 1.682 billion, 3SBio at 0.294 billion, UBTECH at 0.228 billion, and Bilibili-W at 0.138 billion [1] - Southbound funds have continuously net bought Alibaba for 16 days, totaling 41.52389 billion HKD, while net selling Meituan for 4 days, totaling 2.70959 billion HKD [3] Group 2 - Alibaba and Baidu have started using self-designed chips to train their AI models, partially replacing chips produced by Nvidia. Alibaba's Tongyi Qianwen has released the next-generation foundational model architecture Qwen3-Next and open-sourced the Qwen3-Next-80B-A3B series model based on this architecture [4] - Pop Mart has launched its first gold series products under its jewelry brand popop, with the most expensive item being a gold ornament weighing approximately 41 grams, priced over 56,000 RMB. The price of the gold series products will not fluctuate with gold prices but will vary based on craftsmanship, with prices per gram mainly concentrated between 1,300 to 1,700 RMB [4] - Yaojie Ankang's stock price has surged over 18 times since its IPO price of 13.15 HKD in less than three months. The company announced that its core product, Tengrutin combined with Fulvestrant, has received clinical implied approval from the National Medical Products Administration of China for a Phase II clinical trial for recurrent or metastatic breast cancer [4] Group 3 - Meituan is considering issuing dim sum bonds, with multiple investment banks gauging fixed-income investors' interest in potential offshore RMB bonds. Discussions are still in the preliminary stages regarding details such as term, scale, and issuance timing [5] - If successfully priced, this will be Meituan's first issuance of dim sum bonds. Meituan has a 750 million USD bond with a 2.125% coupon maturing on October 28. Last September, Meituan raised a total of 2.5 billion USD through the issuance of two USD bonds [6]